...
首页> 外文期刊>Diagnostic cytopathology >Pap test in a high-risk population comparison of conventional and liquid-base cytology.
【24h】

Pap test in a high-risk population comparison of conventional and liquid-base cytology.

机译:子宫颈抹片检查在高危人群中常规和液基细胞学的比较。

获取原文
获取原文并翻译 | 示例
           

摘要

Liquid-based cytology (LBC) is believed to have better sensitivity than conventional smears (CSs) and offers the possibility to perform molecular assay. The goal of this work was to study the performance of CS and LBC in a high-risk population and to compare the results with the hybrid capture (HC) II for high-risk human papillomavirus (HPV). Samples were collected from selected women with clinical suspicions of low genital tract lesion at Perola Biygnton Hospital (Sao Paulo, Brazil). After CS preparation, the brush was introduced in the endocervix and a new sample was collected and rinsed in the preservative medium of the system. The residual material was used to HC2. From 925 cases, LBC was unsatisfactory in 4 (1.51%) cases and CS was unsatisfactory in 100 cases (10.81%); among theses cases HC2(+) reactions was observed in 54 (54%) CSs and 3 (21.4%) LBCs. Considering cases with atypia of undetermined significance (squamous and glandular), 85 (77.27%) cases from LBC and 44 (86.4%) from CS were positive for HC2 assay for high-risk DNA-HPV. The difference among the methods was not significant (P < 0.38). The diagnosis improvement of LBC in comparison with CS was 86% in satisfactory samples, 92.76% in undetermined atypical lesions (including glandular), 83% in positive low-grade squamous intraepithelial lesions (LSIL(+)), and 86.84% in high-grade SIL(+) (HSIL(+)). HC2(+) reactions were observed in 144 CS cases and 266 LBC cases with abnormalities. Our results have showed that LBC was superior to CS in a high-risk population to detect lesions with high concordance with HC2(+) reactions; CSs also exhibit a high concordance with HC2 assay but with inferior performance to detect lesions.
机译:液基细胞学(LBC)被认为比常规涂片(CSs)具有更好的敏感性,并提供了进行分子分析的可能性。这项工作的目的是研究高危人群中CS和LBC的性能,并将结果与​​混合捕获(HC)II用于高危人乳头瘤病毒(HPV)进行比较。样本是从Perola Biygnton医院(巴西圣保罗)的某些临床怀疑有低生殖道病变的妇女中收集的。 CS制备后,将刷子插入子宫颈内膜,收集新样品,并在系统的防腐介质中冲洗。残留物质用于HC2。 925例中,LBC不满意4例(占1.51%),CS不满意100例(占10.81%);在这些案例中,在54(54%)CS和3(21.4%)LBC中观察到HC2(+)反应。考虑到具有非典型意义的非典型性病例(鳞状和腺性),来自LBC的85例(77.27%)和来自CS的44例(86.4%)的HC2检测为高风险DNA-HPV阳性。这些方法之间的差异不明显(P <0.38)。与CS相比,令人满意的样本中LBC的诊断改善为86%,未确定的非典型病变(包括腺体)为92.76%,低度鳞状上皮内阳性病变(LSIL(+))为83%,高级别为86.84%等级SIL(+)(HSIL(+))。在144例CS患者和266例LBC患者中观察到HC2(+)反应异常。我们的结果表明,在高风险人群中,LBC优于CS,可检测与HC2(+)反应高度一致的病变。 CS还显示出与HC2分析的高度一致性,但检测病变的性能较差。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号